Clinical impact of normal alanine aminotransferase on direct‐acting antiviral outcome in patients with chronic hepatitis C virus infection

by Satoru Joshita, Ayumi Sugiura, Takeji Umemura, Tomoo Yamazaki, Naoyuki Fujimori, Akihiro Matsumoto, Yoko Usami, Eiji Tanaka
Published 2020-08-01

Changes in serum levels of autotaxin with direct-acting antiviral therapy in patients with chronic hepatitis C.

by Tomoo Yamazaki, Satoru Joshita, Takeji Umemura, Yoko Usami, Ayumi Sugiura, Naoyuki Fujimori, Takefumi Kimura, Akihiro Matsumoto, Koji Igarashi, Masao Ota, Eiji Tanaka
Published 2018-01-01

Serum cell death biomarkers for prediction of liver fibrosis and poor prognosis in primary biliary cirrhosis.

by Tomohiro Sekiguchi, Takeji Umemura, Naoyuki Fujimori, Soichiro Shibata, Yuki Ichikawa, Takefumi Kimura, Satoru Joshita, Michiharu Komatsu, Akihiro Matsumoto, Eiji Tanaka, Masao Ota
Published 2015-01-01

Serum Autotaxin Is a Useful Disease Progression Marker in Patients with Primary Biliary Cholangitis

by Satoru Joshita, Takeji Umemura, Yoko Usami, Yuki Yamashita, Gary L. Norman, Ayumi Sugiura, Tomoo Yamazaki, Naoyuki Fujimori, Takefumi Kimura, Akihiro Matsumoto, Koji Igarashi, Kaname Yoshizawa, Masao Ota, Eiji Tanaka
Published 2018-05-01

Effectiveness of Glecaprevir/Pibrentasvir for Hepatitis C: Real-World Experience and Clinical Features of Retreatment Cases

by Ayumi Sugiura, Satoru Joshita, Yuki Yamashita, Tomoo Yamazaki, Naoyuki Fujimori, Takefumi Kimura, Akihiro Matsumoto, Shuichi Wada, Hiromitsu Mori, Soichiro Shibata, Kaname Yoshizawa, Susumu Morita, Kiyoshi Furuta, Atsushi Kamijo, Akihiro Iijima, Satoko Kako, Atsushi Maruyama, Masakazu Kobayashi, Michiharu Komatsu, Makiko Matsumura, Chiharu Miyabayashi, Tetsuya Ichijo, Aki Takeuchi, Yuriko Koike, Yukio Gibo, Toshihisa Tsukadaira, Hiroyuki Inada, Yoshiyuki Nakano, Seiichi Usuda, Kendo Kiyosawa, Eiji Tanaka, Takeji Umemura
Published 2020-04-01